Document is current

Article History

Received: 13 October 2020

Revised: 27 January 2021

Accepted: 16 February 2021

First Online: 3 March 2021

Declarations

:

: The scientific guarantor of this publication is Pr. Ali Guermazi, MD, PhD.

: Ali Guermazi is the President of Boston Imaging Core Lab (BICL), LLC, and a consultant to MerckSerono, AstraZeneca, Pfizer, GE Healthcare, OrthoTrophix, Sanofi, and TissueGene. Frank Roemer and Michel Crema are shareholders of BICL, LLC. Frank Roemer is a consultant to Calibr – California Institute of Biomedical Research. Other authors declare no relationships with any companies whose products or services may be related to the subject matter of the article.

: Lig Li, PhD, kindly provided statistical advice for this manuscript.

: Written informed consent was obtained from all subjects in this study.

: Institutional Review Board approval was obtained from Boston University (#H- 36593).

: Some study subjects or cohorts have been previously reported in: Derman W, Schwellnus MP, Jordaan E, et al <i>Br J Sports Med</i> 2018;52:17–23, and Derman W, Runciman P, Schwellnus M, et al <i>Br J Sports Med</i> 2018;52:24–31.

: • observational• performed at one institution